Cost-Effectiveness Of Tiotropium Versus Omalizumab For Patients With Severe Uncontrolled Allergic Asthma In Us

被引：0
|
作者：
Zafari, Z. [1 ,2 ]
Fitzgerald, M. [2 ]
Marra, C. [1 ]
Sadatsafavi, M. [3 ]
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] Inst Heart Lung Hlth, Vancouver, BC, Canada
[3] Univ British Columbia, Vancuver, BC, Canada
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3712
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
    Zafar Zafari
    Mohsen Sadatsafavi
    J. Mark FitzGerald
    [J]. Cost Effectiveness and Resource Allocation, 16
  • [2] Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
    Zafari, Zafar
    Sadatsafavi, Mohsen
    FitzGerald, J. Mark
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2018, 16
  • [3] Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma
    Buendia, Jefferson Antonio
    Guerrero Patino, Diana
    Cossio-Giraldo, Yamith Eutimio
    [J]. JOURNAL OF ASTHMA, 2022, 59 (10) : 2016 - 2023
  • [4] COST-EFFECTIVENESS ANALYSIS OF OMALIZUMAB IN THE TREATMENT OF UNCONTROLLED SEVERE ALLERGIC ASTHMA IN CHINA
    Zhu, S.
    Xiao, D.
    Wang, L.
    Xuan, J.
    [J]. VALUE IN HEALTH, 2019, 22 : S49 - S49
  • [5] Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients
    Arrobas, A.
    Barbosa, M. P.
    Rabiais, S.
    Vandewalle, B.
    Felix, J.
    [J]. PULMONOLOGY, 2021, 27 (02): : 124 - 133
  • [6] Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma
    Brown, R.
    Turk, F.
    Dale, P.
    Bousquet, J.
    [J]. ALLERGY, 2007, 62 (02) : 149 - 153
  • [7] 0 COST-EFFECTIVENESS OF MEPOLIZUMAB VERSUS OMALIZUMAB AS AN ADJUNCT THERAPY IN PATIENTS WITH UNCONTROLLED ALLERGIC ASTHMA
    Korgaonkar, S.
    Inguva, S.
    Yang, Y.
    [J]. VALUE IN HEALTH, 2018, 21 : S235 - S235
  • [8] Cost-effectiveness of omalizumab for the treatment of moderate-to-severe uncontrolled allergic asthma in the United States
    Sullivan, Patrick W.
    Li, Qianyi
    Bilir, S. Pinar
    Dang, Joseph
    Kavati, Abhishek
    Yang, Ming
    Rajput, Yamina
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (01) : 23 - 32
  • [9] An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma
    Sullivan, S. D.
    Turk, F.
    [J]. ALLERGY, 2008, 63 (06) : 670 - 684
  • [10] Cost-effectiveness of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
    Resta, Emanuela
    Carpagnano, Giovanna Elisiana
    Pelaia, Corrado
    D'Amato, Maria
    Crimi, Nunzio
    Scichilone, Nicola
    Calabrese, Cecilia
    Resta, Onofrio
    Scioscia, Giulia
    Pelaia, Girolamo
    Barbaro, Maria Pia Foschino
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
12345